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ABSTRACT 
 
EVALUATION AND DETERMINATION OF THE SENSITIVITY AND  
SPECIFICITY OF A Treponema pallidum DRIED BLOOD SPOT (DBS) METHOD 
FOR SEROLOGIC DIAGNOSIS OF SYPHILIS 
Background: Syphilis is a sexually transmitted infection (STI) caused by Treponema 
pallidum subspecies pallidum. Syphilis is known as the “great imitator" due to the 
similarity of clinical signs and symptoms to other infectious diseases. The primary 
diagnosis of syphilis relies on clinical findings, including the examination of treponemal 
lesions, and/or serologic tests. Serologic
 
tests are divided into nontreponemal and 
treponemal tests. Nontreponemal
 
tests are useful for screening, while treponemal tests are 
used
 
as confirmatory tests.   
Methods: A total of 200 serum and DBS specimens collected from patients at the Los Angeles 
Municipal Sexually Transmitted Disease Clinics were tested by the DBS and enzyme 
immunoassay (EIA) methods.  These samples were sent to the Syphilis Diagnostics 
Laboratory, Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia for 
testing. Samples were blindly evaluated by the TREP-SPOT
TM
 DBS and the TREP- 
SURE
TM
 EIA methods for the detection of anti-treponemal IgG- and IgM-class 
antibodies. 
Results: The sensitivity of the DBS method was 83% (95% CI, 73.89 - 89.50) and specificity 
was 100% (95% CI, 95.39 - 100)). The positive predictive value and negative predictive values 
were 100% (95% CI, 94.48 - 100) and 85% (95% CI, 77.43 - 91.0), respectively. The efficiency 
of the DBS method was 91.5%.  The kappa value for the agreement between the DBS method and 
EIA assay was 0.83 (95% CI, 0.754 - 0.906). The correlation coefficient (r
2
) between the anti-
treponemal antibody assay results obtained from DBS and serum samples was 0.94. 
Conclusion: DBS is an optimal choice to be used as a screening tool for the detection of 
anti-treponemal antibodies for the diagnosis of syphilis. The detection of anti-treponemal 
antibodies (TREP-SPOT
TM
 DBS EIA) compared favorably to the results of serum-base 
assay (TREP-SURE
TM 
EIA), with an overall concordance of 91.5%. Dried blood spots 
are technically easier to obtain and are suitable blood samples for primary health care 
centers. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background 
 
Syphilis is a sexually transmitted infection (STI) caused by Treponema pallidum 
subspecies pallidum. Syphilis is known as the “great imitator” due to its similarity of 
clinical signs and symptoms to other infectious diseases. The World Health Organization 
(WHO) reports that more than 340 million new cases of STI occur worldwide (WHO, 
2012b) . Globally, STIs are a major public health burden in developing countries.  STIs 
account for one-third of the global burden of disease among women of reproductive age 
(WHO, 2012b).  According to Centers for Disease Control and Prevention (CDC), there 
were over 36,000 documented cases of syphilis in 2006, including 9,756 cases of primary 
and secondary syphilis (CDC, 2010). The incidence of primary and secondary syphilis is 
highest in women 20 to 24 years of age and in men 35 to 39 years of age (CDC, 2012a). 
The prevalence of congenital syphilis in newborns also increased from 2005 to 2006, 
with 339 new cases reported in 2005, compared to 349 cases in 2006 (CDC, 2012a).  The 
cases of syphilis among men who have sex with men (MSM) showed the largest 
increases since 2000 (CDC 2012a).  MSM accounted for almost 62% of syphilis cases in 
2009, up from 7% in 2000.  CDC reported that the primary and secondary syphilis cases 
increased from 13,500 in 2008 to 13,997 in 2009, an increase of 3.7%  (CDC 2012a; 
CDC, 2012b ).  The rate of the primary and secondary syphilis was highest among 
persons aged 20 to 24 years and 25 to 29 years in 2009 (CDC, 2012a ).  
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The primary diagnosis of syphilis relies on clinical findings, including the 
examination of treponemal lesions, and/or serologic tests.  Serologic tests are classified 
into two categories: nontreponemal and treponemal assays.  Nontreponemal tests are 
useful for screening, while treponemal tests are used as confirmatory tests. 
Nontreponemal tests detect the host’s antibody response to nontreponemal (cardiolipin-
lecithin) antigen. Nontreponemal tests include the Venereal Disease Research Laboratory 
(VDRL), the rapid plasma reagin (RPR), the toludine red unheated serum (TRUS), and 
unheated serum reagin (USR) tests (Owusu-Eduse, 2011).  In contrast, all treponemal 
tests allow for the detection of specific treponemal antibodies.  Serologic treponemal tests 
include the microhemagglutination assay for T. pallidum (MHA-TP), T. pallidum particle 
agglutination (TPPA), T. pallidum hemagglutination assay (TPHA), fluorescent 
treponemal antibody absorption (FTA-ABS) test, and enzyme-linked immunosorbent 
assay (ELISA) (Wong, 2011). More recently, rapid and reliable nucleic acid 
amplification methods are available for the detection of T. pallidum in clinical samples 
(Heymans, 2010).  These methods added great value for the diagnosis of congenital 
syphilis, neurosyphilis and early primary syphilis (Heymans, 2010). 
Serum is the specimen of choice for both nontreponemal and treponemal 
serologic tests even though plasma can be used in some nontreponemal tests.  Dried 
blood spots (DBS) have been used for rapid diagnosis of human immunodeficiency virus-
1(Rottinghaus, 2012) and newborn screening for phenylketonuria (De Silva, 2010).  
Sample collection of DBS has never been routinely used for serologic confirmation of 
syphilis. 
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1.2 Purpose of Study 
 
 The aim of this study is to evaluate and determine the sensitivity and specificity of 
a T. pallidum DBS method for serologic diagnosis of syphilis. For the purpose of this 
study, TREP-SURE
TM
 EIA (Phoenix Bio-Tech Corporation, 2010) was used for the in 
vitro diagnostic detection and confirmation of antitreponemal antibodies using a T. 
pallidum TREP-SPOT
TM
 DBS method (Phoenix Airmid Biomedical Corporation, 2012). 
 
 
 1.3 Research Questions 
 
 This thesis will focus on the following questions: 1) Does a T. pallidum DBS 
method provide the sensitivity and specificity for the diagnosis and confirmation of 
syphilis? 2) Can a T. pallidum DBS method be used for the diagnosis and confirmation of 
syphilis? 3) Does a T. pallidum DBS method offer a convenient way to collect and 
transport blood samples for the diagnosis and confirmation of syphilis? 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
The purpose of this study is to evaluate and determine the sensitivity and 
specificity of a T. pallidum DBS method for serologic diagnosis of syphilis. This 
literature review will focus on the following major aspects: the global burden of STIs and 
syphilis, etiology, epidemiology, pathogenesis, clinical signs and symptoms, laboratory 
diagnosis of syphilis, and prevention and control. 
 
2.1 Global burden of sexually transmitted infections 
 STIs are one of the leading causes of acute illness, long-term disability and death. 
Globally, STIs still remain a major public health threat in both developed and developing 
countries.  According to the World Health Organization (WHO), over 340 million new 
cases of STIs reported worldwide in 1999 (WHO, 2012a). The highest incidence of STIs 
per 1000 population has occurred in sub-Saharan Africa (WHO, 2012a).  
An estimated 12.22 million cases of syphilis occurred worldwide in 1999 
according to WHO (WHO, 2012b). In contrast to Western Europe, the newly independent 
states of the former Soviet Union reported an alarming increase in the rates in syphilis 
(WHO, 2001). Syphilis incidence increased from 5 to 15 per 100,000 observed in 1990 to 
as high as 120 to 170 per 100,000 population in 1996 in these countries (WHO, 2001). 
The highest prevalence rate in pregnant women was 3.2% in Djibouti, followed by 3.0% 
in Morocco, and 1.1% in Qatar (WHO, 2001).  CDC estimated that the number of cases 
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of primary and secondary syphilis in U.S. increased from 5,979 to 7,980; the rate 
increased from 2.1 to 2.7 cases per 100,000 population from 2000 to 2004 (MMWR, 
2006).  
STIs are caused by bacterial, parasitic, or viral pathogens. Some of the more 
common pathogens are Chlamydia trachomatis, Hemophilus ducreyi, Neisseria 
gonorrhea, Treponema pallidum, Trichomonas vaginalis, herpes simplex virus 2, human 
papillomavirus, hepatitis B virus, and human immunodeficiency virus (Ratnam, 2005). 
2.2  Etiology and transmission of disease 
 Schaudinn and Hoffmann first identified T. pallidum as the causative agent for 
syphilis in 1905 (de Souza, 2005). More importantly, Schaudinn named this organism by 
using the Greek word trepo (I turn) and nema (thread) with the Latin word pallida (pale). 
Treponema pallidum means “a pale turning thread” (de Souza, 2005). The causative 
agent of syphilis is Treponema pallidum subspecies pallidum. T. pallidum is a member of 
the order Spirochaetales, family Spirochaetaceae, and genus Treponemae. The other 
three species of the genus Treponema cause diseases in humans. These include T. 
pallidum subspecies pertenue, causing yaws; T. pallidum subspecies endemicum, causing 
nonvenereal treponematosis (bejel); and T. carateum, causing pinta. Morphologically, T. 
pallidum is a small, unicellular, tightly coiled and helical organism measuring 6 - 15 µm 
in length and  14 - 0.2 µm in width (CDC, 2009a, 2009b). T. pallidum has not been 
grown successfully on artificial culture media. However, the organism has been 
cultivated in rabbit testicles (Brown, 1920). 
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Syphilis is transmitted primarily through sexual contact. The disease may be 
transmitted from mother to fetus during pregnancy or at birth resulting in congenital 
syphilis. Syphilis can occur through blood transfusion from the donor in early stages of 
infection (Gupta, 2012). Health care providers may acquire the primary lesions on the 
hands after examining unprotected clinical lesions of syphilis. 
T. pallidum only infects humans. Humans are the only known natural reservoir for 
syphilis. The organism does not have a reservoir in animals or the environment (LaFond, 
2006).  The incubation period for syphilis is 10 days to 3 months. The average incubation 
period of primary syphilis is usually about 3 weeks. However, symptoms can appear as 
early as 9 days or as long as 3 months after exposure in rectal infections associated with 
homosexual men (LaFond, 2006). 
2.3  Epidemiology of syphilis 
 STIs are the leading cause of morbidity and mortality among men, women and 
children (CDC, 2009). STIs still remain a major public health problem worldwide, 
especially in developing countries. Globally, about 340 million preventable new cases 
occur every year (WHO, 2001). Syphilis accounts for an estimated 12 million cases; 2 
million of them are pregnant women (WHO, 2001). The 2000 Global Burden of Disease 
Estimates reported that 1.3% of deaths among children under the age of 5 years were due 
to congenital syphilis (WHO, 2001). The annual global number of cases of congenital 
syphilis is estimated to be between 575,000 and 713,600 (Hossain, 2007). The newborn 
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infants have a higher incidence of congenital syphilis than other infections caused by 
human immunodeficiency virus-1 and Clostridium botulism (Rodríguez-Cerdeira, 2012). 
 The total number of primary, secondary, early latent, late, late latent and 
congenital syphilis cases was 44,828 in 2009  in the United States according to CDC 
(CDC, 2010).  During 2008 to 2009, primary and secondary syphilis rates increased 10% 
in the South, 2.7% in the Northeast, and 7.7% in the Midwest (CDC, 2010). In 2009, 
syphilis rates were highest in the South, 6.6 cases per 100,000 population (CDC, 2010). 
 According to CDC in 2009, Louisiana, Georgia, Arkansas, Alabama, Mississippi, 
Texas, Tennessee, North Carolina, New York, Illinois, Florida, Maryland, and California 
reported the highest rates of primary and secondary syphilis (CDC, 2010). These 13 
states accounted for 75% of all U.S. cases of primary and secondary syphilis and exceed 
the national rate of 4.6 cases per 100,000 population (CDC, 2010). Of the 13 states with 
the highest rates of primary and secondary syphilis, 10 states were in the South (CDC, 
2010).  
 
 During 2008 to 2009, the number of primary and secondary syphilis infections in 
men increased from 7.5 to 7.8 cases per 100,000 men, and decreased from 1.5 to 1.4 
cases per 100,000 women during the same period (CDC 2009).  In 2009, the overall rate 
of reported primary and secondary syphilis was highest in people aged 20 to 24 years and 
25 to 29 years, 11.3 cases per 100,00 population, respectively (CDC, 2010). From 2008 
to 2009, the reported incidence of primary and secondary syphilis increased in all ethnic 
groups except non-Hispanic whites and Hispanics. The rate of primary and secondary 
syphilis in non-Hispanics increased by 11.6% (from 17.2 cases per 100,000 population), 
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6.7% in Asian/Pacific Islanders (from 1.5 to 1.6 cases per 100,000 population), and 4.3% 
in American Indians/Alaska Natives (from 2.3% to 2.4 cases per 100,000) (CDC, 2009a). 
From 2008 to 2009, the incidence of primary and secondary syphilis decreased in non-
Hispanic Whites and Hispanics, with a 4.5% decrease in non-Hispanic whites (from 2.2 
to 2.1 per 100,000 population) and 2.2% in Hispanics (from 4.6 to 4.5 cases per 100,000 
population) (CDC, 2009a). 
 
2.4  Pathogenesis, clinical signs and symptoms  
 
Syphilis remains a significant public health challenge. Mechanisms of T. pallidum 
pathogenesis are poorly understood for three reasons: 1) the inability to cultivate the 
causative agent in vitro; 2) the lack of suitable animal models; 3) the limited availability 
of information from human studies. Because of the paucity of human studies, the 
postulated pathogenesis of syphilis is primarily derived from animal models. Some early 
animal studies offered important insight into syphilis pathogenesis (Cameron, 1998). T. 
pallidum enters the body via skin and mucous membranes through small abrasions during 
sexual contact. Magnuson et al. (Magnuson, 1948) demonstrated a darkfield positive 
lesion when two organisms of T. pallidum were intracutaneously inoculated in rabbits. 
After initial entry, symptoms appear, within a few hours after inoculation, as T. pallidum 
navigates the lymphatic system and regional lymph nodes before traveling throughout the 
body via the blood stream (Singh, 1999). In some cases, the organism may remain at the 
site of entry, multiplying and sensitizing lymphocytes, while activating macrophages, 
resulting in the chancre at the site of transmission. Although the exact mechanism by 
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which T. pallidum enters the host cell has not been completely elucidated, it is most 
likely T. pallidum attaches to host cells by specific attachment ligands. It appears that 
penetration and damage of endothelial cells is critical for the pathogenicity and virulence 
of T. pallidum required (Riviere, 1989).  Riviere et al. (Riviere, 1989) studied the 
invasive potential of T. pallidum in vitro and demonstrated the ability of the organism to 
penetrate the endothelial cell monolayer.  
The route of transmission of syphilis is almost always through sexual contact 
however, it can also be acquired congenitally (transmitted transplacentally from an 
infected mother to her fetus).  It can also be transmitted through blood transfusion. 
 Primary syphilis is usually characterized by one or more painless chancres of the 
skin or mucous membranes at the site of inoculation (Kent, 2008). These lesions are 
commonly seen on the genitalia. The changes appear within 3 to 4 weeks after exposure. 
These lesions heal spontaneously after 4 to 6 weeks. Induration is the most common sign 
and occurs in 47% to 92% of cases (Kent, 2008). Additionally, these lesions have 
numerous treponemal organisms and exudates from lesions are highly infectious.  
There is no clear distinction between primary and secondary syphilis. However, 
secondary syphilis begins about 1 to 2 months after the appearance of the primary 
chancre (Kent, 2008). The secondary stage is characterized by rash, mucocutaneous 
lesions, and lymphadenopathy (Kent, 2008).  A rash can develop over the body and 
commonly includes the palms of the hands and the soles of the feet (Euerle, 2011). The 
skin rash usually heals in 2 to 12 weeks on its own without scarring. Hypertrophic 
papular lesions can occur on the vulva or anus and can easily be confused with human 
10 
 
papilomavirus infection (Euerle, 2011). The other symptoms of secondary syphilis 
manifest as generalized lymphadenopathy, malaise, sore throat, headache, splenomegaly, 
and arthralgia (Euerle, 2011). This stage also heals spontaneously even without treatment 
in 3 to 12 weeks. Secondary syphilis can last from 2 to 6 weeks. The organisms continue 
to disseminate throughout the body via lymphatic and hematogenous spread. 
 Latent syphilis is referred to as the period after infection when T. pallidum 
continues in the body of the infected person without clinical manifestations of disease. 
Latent syphilis follows the resolution of secondary syphilis. Latent syphilis is subdivided 
into early, late, and unknown categories based on the duration of infection. Latent 
syphilis is classified as "early latent" if the infection is known to be less than one year in 
duration, "late latent" if the infection is known to be greater than one year in duration, or 
"latent syphilis of unknown duration" if the duration of infection is unknown (Euerle, 
2011). Common signs and symptoms of latent syphilis include difficulty coordinating 
muscle movements, numbness, paralysis, dementia, and gradual blindness (Euerle, 2011). 
 Tertiary syphilis occurs 15 to 30 years after the initial infection. This stage is 
marked by long-term complication of the disease. Three major forms of tertiary syphilis 
include late benign (gummatous), cardiovascular syphilis, and neurosyphilis (Singh, 
1999). The tertiary stage involves only a gumma formation and cardiovascular 
involvement without clinical manifestations of neurosyphilis. Late benign syphilis 
typically causes aortitis or gummatous changes of the skin, bone, or viscera. 
Cardiovascular syphilis occurs between 10 and 30 years after the initial infection. The 
most common manifestaton of cardiovascular syphilis is aortitis, typically involves the 
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ascending aorta (Karnath, 2009). Syphilitic aneurysms are the most common 
complication of syphilitic aortitis and complicated by aortic insufficiency and 
regurgitation (Karnath, 2009). Neurosyphilis is an infection of the central nervous system 
invaded by T. pallidum. Neurosyphilis can occur at almost any stage of syphilis. Early 
neurosyphilis presents with the involvement of meninges and menigovascular system 
after weeks to years of primary infection. Brain and spinal cord involvement usually 
indicates late syphilis and occurs years to decades after initial infection (Singh, 1999). As 
an untreated complication of progresses, it invades the spinal cord, impairs muscle 
function, and causes nerve damage. This condition is referred to as Tabes dorsalis. Tabes 
dosalis causes a slow degeneration of the covering of nerve cells and nerve fibers that 
relay sensory information to the brain (Singh, 1999). Without medical intervention, it can 
lead to mild to severe dementia, paralysis, and blindness. However, even with treatment, 
damage to nerve cells and fibers in the spinal cord cannot be reversed. The most common 
signs in the tertiary stage include fever, painful and, non-healing skin ulcers, and bone 
pain (Euerle, 2011; Karnath, 2009; Kent, 2008) 
 Congenital syphilis is a multisystem infection caused by T. pallidum and 
transmitted placentally to fetus. Transmission to the fetus in pregnancy can occur during 
any stage of syphilis. Untreated syphilis during pregnancy is associated with stillbirth, 
neonatal death, bone deformities, and neurologic complications (WHO, 2011). Early 
signs and symptoms of congenital syphilis are highly variable. Most clinical symptoms 
are not seen at birth but show within the 3 months of infant life. Clinical signs and 
symptoms of congenital syphilis in infants less than 2 years  of age may manifest signs of 
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hepatosplenomegaly, rash, codyloma lata, jaundice, hemolytic anemia, hrombocytopenia, 
osteochondritis, and pseudoparalysis (Arnold, 2000; Rodriguez-Cerdeira, 2012).   Late 
congenital syphilis in older children typically manifests after two years of life and causes 
gummatous ulcers, periosteal lesions, paresis, tabes, optic atrophy, interstitial keratitis, 
sensorineural deafness, and dental deformities (Rodriguez-Cerdeira, 2012). 
 Yaws is a highly contagious treponematosis. This disease is caused by T. pallidum 
subspecies pertenue. Yaws is not spread by sexual contact. Direct skin-to-skin contact is 
the main route for transmission. The disease is similar to syphilis and can persist for 
many years as a chronic, relapsing infection. Yaws is more common in children with a 
peak incidence in those 6 to 10 years of age. Yaws is endemic in the tropical and sub-
tropical areas with hot temperatures, high humidity, and heavy rainfall. The prevalence of 
the disease is higher in areas with poor sanitation, overcrowding, and lack of public 
health surveillance system (Farnsworth, 2006). The primary stage of the disease begins 2 
to 4 weeks after exposure. A small papule known as “mother yaws” develops at the site 
of inoculation. A papule gradually develops into a papilloma without treatment. Regional 
lymphadenopathy, fever and arthralgias may be seen with the primary stage of yaws 
(Farnsworth, 2006). The “mother yaws” may last from several weeks to months and may 
last into the secondary yaws. Secondary yaws tends to be more severe and involves in the 
skin, palmoplantar and bones. The characteristics of these lesions exhibit large raised 
papillomas and papules after a period of latency (about 6 to 16 weeks after the primary 
stage).  Periostitis, osteitis, polydactylitis, arthralgias, generalized lymphadenopathy, 
headaches, and malaise may be associated with the secondary stage of yaws (Farnsworth, 
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2006). Five to ten years after infection, 10% of patients enter a tertiary stage of the 
disease which is typically characterized by destructive skin lesions and severely 
deformed bone and joint lesions (Farnsworth, 2006).  
 T. pallidum subspecies endemicum is the causative agent of bejel. The infection is 
very similar to syphilis but is not sexually transmitted. The primary route of transmission 
is through direct contract with infectious lesions on the skin and mucous membranes. 
However, the disease can spread by sharing common eating and drinking utensils. The 
main reservoir is children 2 to 15 years of age. Bejel is more common in dry, hot climates 
in the eastern Mediterranean region and in Saharan West Africa (Falabella, 1994; 
Farnsworth, 2006).  In the early stage of infection, clinical features are rarely present but 
lesions are seen in the mouth, the back of the lips, and on the cheeks. Secondary lesions 
may persist in the mouth. The secondary lesions may be papules, macules, or various 
other rashes. A generalized lymphadenopathy is common at this stage (Farnsworth, 
2006). Tertiary bejel can occur as early as 6 months or as late as several years after initial 
clinical manifestations resolve. Gangosa, uveitis, optic atrophy, and chorioretinits may 
occur in the late tertiary stage of infection (Falabella, 1994). The organism may infect the 
periosteal space, which leads to severe bone deformities. 
 Pinta is an acute and chronic nonvenereal treponematosis caused by Treponema 
carateum. Pinta occurs primarily in remote rural areas of Central and South America. 
Brazil, Venezuela, Columbia, Peru, Ecuador, and Mexico have the highest prevalence of 
the disease. Pinta is more common in early to late adulthood (Farnsworth, 2006). The 
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exact mode of transmission is unknown, but pinta is most likely transmitted by direct skin 
or, mucous membrane contact or by fomite contact (Farnsworth, 2006). In the early-stage 
disease, a papule appears on the uncovered part of the body. After a few weeks or 
months, the papules become small patches. These patches become hypochromic after 
several months and may persist for many years. The face and extremities are often the 
most affected sites. The secondary stage of pinta occurs between 1 and 12 months after 
the primary lesion stage. Many flat, red, scaly, lesions occur either near the primary 
lesion, or scattered around the body. The late stage generally develops 2 to 4 years after 
the onset of the disease and is characterized by the formation of colorless lesions. Unlike 
other endemic treponematosis, pinta has not been implicated in congenital, cardiac, and 
neurological abnormalities. Pinta is a rare infectious tropical disease affecting only the 
skin (Falabella, 1994; Farnsworth, 2006). 
2.5  Laboratory diagnosis of syphilis and prevention 
The diagnosis of syphilis remains more challenging than most other infections 
due to the inability of the organism to grow in culture. The laboratory diagnosis of 
syphilis has primarily relied on the host immunologic response or detection of the 
organism from active lesions. The laboratory tests for syphilis are divided into two broad 
classes: direct and indirect methods. Direct detection methods include darkfield 
microscopy, immunofluorescent staining, and nucleic acid amplication tests (NAATs).  
Darkfield microscopy is used for the detection of T. pallidum from lesions or aspirates 
collected at the primary stage of syphilis. Histological examination of infected tissues 
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using the polymerase chain reaction (PCR) is another example of direct method for the 
diagnosis of syphilis. These tests are most useful for the diagnosis of primary, secondary, 
and early congenital syphilis (Herremans, 2010).  More recently, a number of NAATs 
have been used for the detection of T. pallidium in clinical specimens. These methods are 
not only useful for diagnosis of primary, secondary, and early congenital syphilis but also 
are suitable for monitoring the response to therapy (Ratnam, 2005). 
Serological tests, the most common laboratory method, continue to play a 
significant role in the diagnosis and management of the disease. Indirect diagnosis is 
based on serological tests for the detection of specific T. pallidum antibodies. Serological 
tests fall into two classes: nontreponemal tests for screening, and treponemal tests for 
confirmation. Nontreponemal assays are widely used for syphilis screening, monitoring 
response to treatment, and determining the status of re-infection.  Nontreponemal tests 
include the Venereal Research Laboratory (VDRL), the rapid plasma regain (RPR), the 
toluidine red untreated serum (TRUS), and untreated serum regain (USR) tests. The RPR 
and VDRL tests are the most commonly used nontreponemal tests for diagnosis of 
syphilis (Larsen, 1995). Known as cardiolipin tests, nontreponemal tests use an antigen, 
which contains standardized amounts of cardiolipin, cholesterol-lecithin. These assays 
detect both immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies formed by 
the host in response to the lipoidal substance released from either damaged host cells or 
infected treponemes. However, these nontreponemal tests have lower sensitivity and 
specificity (Larsen, 1995). Both RPR and VDRL tests are flocculation tests performed in 
a similar manner. The RPR tests uses a stabilized VDRL antigen mixed with charcoal 
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particles. When antigen-antibody complexes are formed with a positive serum, black 
clumps show up and remain as flocculates or clumps. A high rate of false-positives can 
occur in a low-prevalence population of patients. More importantly, false-positive results 
are usually due to autoimmune disease, drug addiction, acute viral infections, malaria, 
leprosy, mononucleosis, lupus erythematosus, and recent immunizations (Larsen, 1995).        
The advantage of nontreponemal tests is that they have a higher correlation with disease 
activity. Another advantage of the VDRL test is that it can be performed on cerebrospinal 
fluid (CSF) or serum and can be used to diagnose neurosyphilis. However, RPR cannot 
be used for testing CSF specimens due to lack of its sensitivity and specificity (Larsen, 
1995). The USR test is another nontreponemal test that detects antilipoidal antibodies in 
patients with syphilis. A positive USR may indicate a past or present infection with T. 
pallidum. The TRUST is a macroscopic nontreponemal flocculation card test for 
screening syphilis. It also detects IgM and IgG antibodies to lipoid material from 
damaged host cells or cardiolipin released by the treponemes. With a positive test, a red 
flocculent forms when the TRUST antigen is mixed with a positive serum on a plastic-
coated card. Biological false-positive reactions can occur in patients with autoimmune 
disease (Larsen, 1995). A prozone phenomenon can also cause false-negative reactions 
with these tests.  
The second category of indirect tests is the treponemal tests. All treponemal tests 
use the T. pallidum antigen to detect specific anti-treponemal antibodies in serum. 
Treponemal assays are most often used to confirm the diagnosis of syphilis in patients 
with a reactive RPR or VDRL and rule out biological false positive results from 
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nontreponemal assays. Treponemal tests include the T. pallidum particle agglutination 
(TP-PA), microhemagglutination assay with T. pallidum antigen (MHA-TP), fluorescent 
treponemal antibody-absorption test (FTA-ABS), Western blot test (WB) and enzyme 
immunoassay (EIA). The TP-PA assay is a qualitative gelatin particle agglutination assay 
used for the detection of specific T. pallidum antibodies in human sera or plasma. The 
TP-PA is usually reactive in primary and secondary syphilis. The MHA-TP test is a 
passive agglutination test based on the agglutination of gel particles sensitized with T. 
pallidum antigens by antibodies found in the patient's serum (Larsen, 1995; Owusu-
Eduse, 2011; Ratnam, 2005). This test is a confirmatory test to replace the (MHA-TP). 
The TP-PA test is used to confirm the diagnosis of syphilis in patients with a reactive 
RPR or VDRL.  One advantage of this test is that the TP-PA test is as sensitive as the 
FTA-ABS test in the first stage of syphilis and is just as useful as the RPR in monitoring 
response to therapy. The FTA-ABS test is an indirect immunofluorescent antibody test. It 
detects antibodies to T. pallidum and can be used to detect syphilis infection at any stage 
of the disease. The test is mainly used to rule out biologic false-positives on the 
treponemal test reactions and to detect late syphilis in which nontreponemal test result 
may be nonreactive. The FTA-ABS test can be performed on either CSF or serum. A 
positive result of FTA-ABS-CSF assay can be used to confirm the diagnosis of 
neurosyphilis. The FTA-ABS-CSF assay has a sensitivity and specificity for 
neurosyphilis of 100% and 99.2%, respectively (LaFond, 2006). The WB test is also 
known as immunoblotting. In the treponemal WB, the resolved T. pallidum proteins are 
separated by gel-electrophoresis based on their molecular size (Byrne, 1992). These 
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proteins are transferred by electrophoresis to a nitrocellulose membrane, which is dried 
and cut into strips. These strips are incubated with patient’s serum and antigen-antibody 
complexes are seen by adding enzyme-conjugated anti-human globulin followed by 
substrate, causing a color change. Lastly, EIAs are used for the detection of treponemal 
antibodies in serum. In these tests, the microtiter plate is coated with highly purified 
specific T. pallidum antigen. If the T. pallidum-specific antibodies are present in serum, 
they bind to and become immobilized by the antigen pre-coated on the microtiter wells. 
Only those microtiter wells that contain the T. pallidum IgG/IgM specific antibodies and 
horseradish peroxidase (HRPO) conjugate, and show a change in color. A change in color 
indicates a positive test. The ELISA tests can use various recombinant antigens to detect 
T. pallidum specific IgG, IgM, and IgA antibodies in serum or plasma samples (Larsen, 
1995). The intensity of the color change is directly proportional to the amount of 
antibody concentration. This makes the test an effective diagnostic tool in all stages of 
syphilis with exception of early primary syphilis.   
 
There are 4 major strategies to prevent and control syphilis: 1) education and 
counseling of persons at risk; 2) identification of symptomatic and asymptomatic persons 
not seeking treatment, 3) effective diagnosis and treatment; and 4) identification, 
evaluation, treatment, and counseling of sex partners who are infected with syphilis. 
 Educating the general public about the serious consequences of syphilis and 
reducing the risk of the disease transmission are important strategies in the prevention of 
syphilis. For example, condom education is effective in decreasing the transmission of 
syphilis and HIV. Condoms have played a significant role in preventing the sexual 
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transmission of HIV since the beginning of the epidemic (CDC, 2011). Many 
epidemiological studies cited that consistent condom use was found to reduce the 
transmission of HIV and STIs by 64% and 42%, respectively (CDC, 2010). According to 
the National Institute of Health and the National Institute of Allergy and Infectious 
Diseases, syphilis transmission is reduced by 29% with typical use (CDC, 2011)  
Behavioral interventions for syphilis prevention are another integral component of 
the public education program. The public education program should also focus on “safer 
sex practices” and risk reduction strategies and risk behaviors. Counseling is an essential 
part of primary prevention strategies for reducing the transmission of syphilis. For 
example, trained counselors can discuss an individual’s risky behaviors and provide the 
necessary information on how to reduce their risk for contracting syphilis. 
According to the United States Preventive Services Task Force recommendation 
published in 1996, all pregnant women and persons at high risk for infection should be 
screened by routine serological testing for syphilis (Calonge, 2004). There is compelling 
evidence that screening for syphilis reduces morbidity or morality, the incidence of 
congenital syphilis in newborns, and disease transmission. A study evaluating the impact 
of serological screening testing in pregnant women revealed a decrease in the proportion 
of infants with clinical signs and symptoms syphilis, suggesting early detection and 
intervention can prevent the development of clinical disease with appropriate 
interventions (Calonge, 2004). Syphilis is a highly prevalent infection among MSM and 
transgender people, particularly among MSM living with HIV (WHO, 2010).  An early 
diagnosis of syphilis in MSM and other high “risk group” would provide timely treatment 
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and benefit the individual and partners. Targeting the screening of the ‘risk group” is 
useful in the control of transmission of the disease.  
There are many effective ways to prevent, diagnose, and treat syphilis. Prompt 
diagnosis and effective treatment of syphilis are necessary to avoid the serious 
complications and the spread of the disease. Treatment based on presumptive diagnosis 
of syphilis should be inexpensive, simple, safe, and effective. Targeting and treating the 
highly “risk group” have been very useful. For example, selective mass treatment of 
commercial sex workers prevented the spread of ongoing syphilis epidemic in Fresno, 
California in 1977 (Singh, 1999). WHO also adopted the same strategy to eradicate yaws.  
The effective use of this mass treatment strategy markedly lowered the prevalence of the 
disease in certain communities.  
Prompt notification and treatment of sex partners after diagnosis of syphilis are 
essential to reduce the spread of disease and the risk of reinfection. This program can be 
effective if interventions focus on the importance of notification, improvement of 
communication skills, development of contact tracing programs and expedient partner 
therapy. The partner notification process involves a series of interrelated activities such 
as, interviewing the infected patient to obtain a complete list of exposed sex partners and 
locating these individuals in the community. Examination of partner notification data 
could provide valuable information regarding the social networks in a community and 
capture opportunities for targeted interventions. This allows for assistance in identifying 
and treating potentially infected sexual partners. All sexual partners need to be notified 
about an infection so they can be tested and, if necessary, treated. Partner services should 
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be carefully monitored and evaluated for completeness, timeliness, effectiveness, and 
cost-effectiveness. 
Finally, penicillin is the drug of choice for treating all stages of syphilis according 
to the 2010 CDC STD Treatment Guidelines (MMWR, 2010). Additionally, penicillin 
remains the mainstay of treatment for neurosyphilis, congenital syphilis, or syphilis 
during pregnancy (MMWR, 2010). Alternate therapeutic agents are also available for 
treating penicillin-allergic patients with primary and secondary syphilis. Tetracycline, 
erythromycin, and ceftriaxone are effective for treating patients allergic to penicillin. The 
CDC 2010 STD Treatment Guidelines reports the effectiveness of azithromycin in 
treating early syphilis (CDC, 2010). However, there are some cases of treatment failure 
due to azithromycin-resistant mutations in T pallidum in several areas of the United 
States (MMWR, 2010). Additional studies are needed to confirm the efficacy of 
azithromycin before this treatment can be routinely used for treating syphilis. Despite 
efforts to develop a safe and effective syphilis vaccine, there is currently no vaccine to 
prevent syphilis. To this day, penicillin continues to be the drug of choice for the 
treatment of all stages of syphilis.   
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Chapter III 
 
 
METHODOLOGY 
 
 
 
 The study evaluated the sensitivity and specificity of a T. pallidum DBS method 
for serologic diagnosis of syphilis in comparison to serum results. 
 
3.1  Study population and enrollment 
 
 A total of 200 serum and DBS specimens collected from patients at the Los Angeles 
Municipal Sexually Transmitted Disease Clinics.  Eligible subjects were those ≥20 years old 
with symptoms of a chancre on the genitals, rectum or mouth, swelling of the lymph 
nodes in the groin, fever, headache, achiness, loss of appetite, rash, painful non-healing 
skin ulcers and bone pain. Written informed consent was obtained from all study 
subjects, and signs and symptoms of syphilis, and medication history were assessed. DBS 
and serum specimens were collected from patients undergoing syphilis evaluation and 
testing in the STI clinics. These samples were sent to the Syphilis Diagnostics Lab, 
Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia testing. Samples 
were blindly evaluated by the DBS and the TREP- SURE
TM
 EIA methods for the 
detection of anti-treponemal IgG- and IgM-class antibodies.  
3. 2 Data sources and procedure 
 
 A total of 200 DBS and serum specimens were collected from participants in the 
study. The study was conducted during a 52 week period in September 2011 to 
September 2012. TREP- SURE
TM
 was performed on serum at baseline (gold standard) 
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and was compared with DBS results. TREP- SURE
TM  
is a qualitative EIA for the in vitro 
diagnostic detection of T. pallidum antibodies in human serum or plasma. This kit is 
commercially available and designed as a confirmatory test for T. pallidum. In this assay, 
the specific recombinant treponemal antigens are pre-coated on the microtiter plate wells. 
Patient sera (100 µl undiluted) and controls were added to the wells and incubated for 60 
minutes at 37°C.  The contents in the wells were discarded and washed 4 times with 300 
µL per well of Wash Buffer Working Solution. Then, enzyme conjugated (100 µl) 
antigens were added to all wells and incubated for 30 minutes at 37°C. Again, the 
contents in the wells were discarded and washed 4 times with 300µL per well of Wash 
Buffer Working Solution after incubation. Tetramethylbenzidine (TMB) substrate 
solution (100 µl) was added to all wells and incubated the plate for15 (±2) minutes at 
37°C, protected from light. Finally, Stop Solution (100 µl) was added to all wells. The 
plate microtiter plate wells were read within15 minutes with optical density at 450 nm 
and results were calculated. If specific anti-treponemal antibodies were present in the 
patient’s serum, T. pallidum antibodies specifically were bound to the immunized 
antigens on the wells. The antigen-antibody complexes reacted with HRPO conjugated 
treponemal antigen. After a second washing step which removes the unbound conjugates, 
a color reaction takes place on the well as a result of addition of the peroxidase substrate, 
TMB. A color change is measured after adding stop solution. The amount of antibody 
present in the patient’s serum is directly proportional to the color intensity in the 
microtiter wells. Results are expressed as an Optical Density (OD). If OD is greater than 
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1.2 it is considered positive and less than 0.8 as negative. If OD is between 0.8 and 1.1, it 
is considered an equivocal result. The complete assay takes about 3 hours. 
  For the DBS testing method (TREP-SPOT
TM 
DBS)  two  6.0 - 6.2 mm blood discs 
were punched  from patient’s dried blood spot card using a puncher and DBS discs were 
placed in 300 µl elution buffer, placed on a shaker on low speed and incubated for 
overnight at 4°C. The contents in the wells (100 µl) were transferred to the testing plate 
and 100 µl elution buffer was added to all wells in the plate and incubated for 30 minutes 
at 37°C. The contents in the wells were discarded and washed five times with 300µL per 
well of Wash Buffer Working Solution. Then, enzyme conjugated (100 µl) antigens were 
added to all wells and incubated for 30 minutes at room temperature (RT). Again, the 
contents in the wells were discarded and washed 4 times with 300µL per well of Wash 
Buffer Working Solution after incubation. TMB substrate solution (100 µl) was added to 
all wells and the plate was incubated for 10 minutes at RT. Finally, Stop Solution (100 
µl) was added to all wells. The microtiter plate wells were read within 15 minutes with 
optical density at 450 nm and calculated results as same as the TREP- SURE
TM
 method. 
 
3.3 Data analysis 
 
To evaluate performance characteristics, the following values were used: true positive 
(TP), false positive (FP), true negative (TN), and false negative (FN).  A true positive is 
when the patient has the disease and the test is positive by the gold standard. Sensitivity, 
specificity, positive predictive value (PPV), negative predictive value (NPV), and 
efficiency (E) were calculated. The following formulas were used to calculate test 
indices:  
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1) sensitivity = [TP/(TP + FN)] × 100;  
2) specificity = [TN/(TN + FP)] × 100;  
3) PPV = [TP/(TP + FP)]  x 100;  
4) NPV = [TN/(TN + FN)]  x 100;   
5)  E = [(TP + TN)/(TP + FP + FN + TN)] x 100.  
All statistical calculations were performed using the Microsoft Office Excel 2010 and 
Clinical Calculator 1 - VassarStats. Statistical Computation Web. Kappa coefficients 
were calculated as a measure of agreement using the Chest X-ray Computation Web 
(http://www.graphpad.com/quickcalcs/kappa1/). The agreement of the results by kappa 
(κ) values is categorized as near perfect (0.81 to 1.0), substantial (0.61 to 0.8), moderate 
(0.41to 0.6), fair (0.21 to 0.4), slight (0 to 0.2), or poor (<0). Correlation coefficients (r
2
) 
measure the strength of association between two values. The value of a correlation 
coefficient ranges between -1 and 1.  The greater the absolute value of a correlation 
coefficient, the stronger the linear relationship. The strongest linear relationship is shown 
by a correlation coefficient of -1 or 1.  The weakest linear relationship is shown by a 
correlation coefficient equal to 0. 
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Chapter IV 
 
 
RESULTS 
 
 The study was designed to determine the sensitivity and specificity of a T. 
pallidum DBS method for serologic diagnosis of syphilis in comparison to serum results, 
by answering the following 3 questions: 
1. Does a T. pallidum dried blood spot method provide high sensitivity and 
specificity for the diagnosis and confirmation of syphilis?  
2. Can a T. pallidum dried blood spot method be used for the diagnosis and 
confirmation of syphilis?  
3. Does a T. pallidum dried blood spot method offer an easy and convenient 
way to collect and transport blood samples for the diagnosis and 
confirmation of syphilis? 
4.1 The performance characteristics of DBS method 
A total of 200 serum and DBS specimens collected from patients at the Los Angeles 
Municipal Sexually Transmitted Disease Clinics were tested by the DBS and EIA methods.  In 
all, the 100 specimens found to be reactive by the TREP-SURE
TM
 EIA were tested by the 
TREP-SPOT
TM 
DBS EIA.  As shown in Figure 1, 83 were found to be reactive and 17 
were found to be nonreactive by the TREP-SPOT
TM 
DBS EIA.  As shown in Table 1, 
sensitivity, specificity, positive predictive value, negative predictive value, efficiency were 
calculated using the formula below in Table 1.  
The sensitivity of the DBS method was 83% (95% CI, 73.89  - 89.50) and specificity was 
100% (95%  CI, 95.39 - 100)). The positive predictive value and negative predictive values were 
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100% (95% CI, 94.48 – 100) and 85% (95% CI , 77.43 - 91.0),  respectively. The efficiency of 
the DBS method was 91.5%.  The kappa (κ) value for the agreement between the DBS method 
and EIA assay was 0.83 (95% CI, 0.754 - 0.906). The correlation coefficient (r
2
) between the 
anti-treponemal antibody assay results obtained from DBS and serum samples is shown in Figure 
1, demonstrating, r
2
 = 0.94. Comparison of these results demonstrated a statistically significant 
positive correlation. 
4.2       DBS  method for the diagnosis of syphilis 
These results indicate that DBS method can be used to detect anti-treponemal 
antibody in DBS samples. The DBS method demonstrated less sensitive (83% sensitivity) 
than the TREP-SURE
TM
 EIA assay for the diagnosis of syphilis, but was significantly 
specific (100% specificity).  The DBS method is an alternative to the use of combined 
VDRL and RPR tests for screening for syphilis. If the DBS method is used for screening 
alternative treponemal test, TPHA should be used for confirmatory testing. The method is 
particularly useful to surveillance in countries with limited resources settings. 
Table 1. Comparison of DBS And Serum Sample  
  SERUM 
SAMPLE 
  
  POSTIVE NEGATIVE TOTAL 
DBS POSTIVE  TP     83 FP     0     83 
SAMPLE NEGATIVE FN     17 TN    100 117 
 TOTAL 100 100 200 
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Table 2. Sensitivity, Specificity, Positive Predictive Value, Negative Predictive 
Value, Efficiency, Kappa, and Correlation Coefficient On 200 Dried Blood Samples 
Against Gold Standard Of The TREP-SURE
TM
 EIA In Serum  
 
 
  95% confidence Interval 
 
Estimated 
Value 
Lower Limit                                    Upper 
Limit 
Sensitivity 0.83 
  0.73891                                             
0.89506 
Specificity 1   0.95389                                                 1 
Positive predictive value 1   0.94487                                                 1 
Negative predictive value 0.854701 
  0.77473                                             
0.9106 
Efficiency 0.915   
Kappa 0.83 0.754                                                 0.906 
Correlation coefficient 0.94  
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 Figure 1. Correlation DBS And Serum Index Values 
 
4.3 Collection and transport of DBS specimens 
The T. pallidum dried blood spot method offers an easy and convenient way to collect 
and transport blood samples for the diagnosis of syphilis. Sample ccollection using the 
DBS technique is simple as shown Figure 2.  As shown in Figure 3, dried blood spots can 
be used as an easy and inexpensive means for the collection and storage of peripheral 
blood specimens from infants, children and adults in settings where collection and 
storage of plasma is not optimal. No special handling is needed.  DBS sampling would be 
a good choice to be used as a screening tool for the screening of syphilis. Some risks 
associated with transport and shipping are minimized because DBS cannot leak or be 
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broken in transit. Another advantage of DBS samples over routine serum/plasma samples 
is that only a small quality of blood, typically 50 µl, is required to make one dried blood 
spot. DBS specimens are easy to collect and store, and can be a convenient alternative to 
plasma or serum in resources-limited settings. 
Figure 2. Dried Blood Spot Collection Card 
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Figure 3. A Collected Blood Sample  
 
4.4  Summary of results 
To summarize, we found that the sensitivity of the DBS method was 83% ((95%, CI, 73.89 - 
89.50) and specificity was 100% (95% CI, 95.39 - 100). The positive predictive value and 
negative predictive values were 100% (95% CI, 94.48 -100) and 85% (95% CI, 77.43 - 91.0), 
respectively. The efficiency of the DBS method was 91.5%.  The kappa value for the agreement 
between the DBS method and EIA assay was 0.83 (95% CI, 0.745 - 0.906). The correlation 
coefficient (r
2
) between the anti-treponemal antibody assay results obtained from DBS and serum 
samples was 0.94.  
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Chapter V 
DISCUSSION AND CONCLUSION 
5.1  Discussion 
 We evaluated the sensitivity, specificity, positive predictive value, negative 
predictive value, efficiency (overall agreement), kappa and correlation coefficient of the 
TREP-SPOT
TM 
DBS assay, comparing it with the most commonly used reference test for 
the diagnosis of syphilis. The sensitivity, specificity, positive predictive value, negative 
predictive value, and efficiency (overall agreement) were 83%, 100%, 100%, 85%, and 
91.5%,  respectively, when tested on 200 DBS and serum specimens. The ideal test is one 
that has very high sensitivity and specificity, so that most true cases are identified and 
most non-cases are excluded. The results obtained showed lower sensitivity and high 
specificity of the TREP-SPOT
TM
 DBS EIA when compared with the TREP-SURE
TM
 
EIA.  As shown in Table 1, a total of 200 specimens tested, 83 were found to be reactive 
by the TREP-SPOT
TM 
DBS EIA and 100 were found to be nonreactive by the TREP-
SURE
TM
 EIA. Of the 100 TREP-SURE
TM
 EIA-reactive specimens, 17 were nonreactive 
by the TREP-SPOT
TM 
DBS EIA. These false negative results may be due to a very small 
concentration of antitreponemal antibodies present in the DBS samples.  
The main factors influencing the low sensitivity (83%) could be due to the 
following three reasons: the amount of blood, dilution and cut-off values used. The 
amount of blood used for the preparation of the DBS samples was very minute using 
aliquots of only 5 μl of whole blood. Blood from the DBS punched disc was eluted with 
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100 μl of eluent buffer, further diluting the sample to 1:20 dilution. Therefore, the assay 
titers obtained from DBS samples were shown to be lower than the titers from the serum 
samples. Lastly, the same cut-off values (index values) used for the TREP-SURE
TM
 EIA 
was used for the DBS samples, when they should not be. 
In our example, the TREP-SPOT
TM
 DBS EIA shows very high specificity (100%) 
for the detection of anti-treponemal antibodies. This demonstrates that the DBS sample 
method is unlikely to yield a false positive result. The specificity is the proportion of 
individuals without the disease who are correctly identified by the test as not having it. 
The positive predictive and negative predictive values were found to be 100% and 84%, 
respectively. When disease prevalence is relatively low, the positive predictive value 
(PPV) is low and false-positive test results are more likely. By contrast, when disease 
prevalence is low, the negative predictive value (NPV) is high, and negative results are 
more likely to be true. Sensitivity and specificity, the PPV and NPV will change with the 
prevalence of a disease. For rare diseases, the PPV will always be low or lower, even 
when a test is near perfect in terms of sensitivity and specificity. 
The TREP-SPOT
TM
 DBS showed efficiency (91%) with the TREP-SURE
TM
 EIA 
for testing anti-treponemal antibodies. A high efficiency was measured between these 
two assays using DBS and serum specimens. A kappa value of 0.83 (95% CI, 0.754 - 
0.906) was found for the agreement between the TREP-SPOT
TM
 DBS and the TREP-
SURE
TM
, showing good agreement between these two tests. The TREP-SPOT
TM
 DBS 
EIA showed near perfect correlation (R
2
 = 0.91). 
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In summary, the findings indicate that dried blood spots are a feasible alternative 
to serum for serologic diagnosis of syphilis. DBS samples compared favorably to the 
results of the TREP-SURE
TM  
EIA, with an overall concordance of 91%. Dried blood 
spots are a convenient alternative to serum/plasma and are suitable for blood sampling in 
the primary health care setting. Studies shown on DBS samples in resource-limited 
settings have proven the usefulness and accuracy of these samples for the serological and 
molecular diagnosis of HIV and Hepatitis infections (Lee, 2011; Patton, 2006). 
5.2 Study Limitations 
This study has a number of limitations. First, we did not use a large study sample 
size. The small sample sizes (200 specimens) possibly reduced the power of the study to 
detect differences between the methods.  The influence of sample size on the power of a 
test is critical. The larger the sample size in the future study will assure the greater 
statistical significance between the TREP-SURE
TM
 EIA and the TREP-SPOT
TM
 DBS 
EIA. Second, all patients enrolled in the  study did not provide clinical information 
(underlying diseases, disorders, or conditions) that are likely to have a large bearing on 
the ability of the test  to reliably rule out the possibly of false positive and negative 
results. It is well documented that Tuberculosis, Lyme disease, human immune 
deficiency virus (HIV) infections, and leptospirosis can cause biological false positives in 
syphilis (Ratnam, 2005). In contract, the latent syphilis and HIV co-infected with 
Tuberculosis can also cause biological false negatives in patients with syphilis (Ratnam, 
2005).  It is possible that seventeen false negative (17) results from the DBS samples 
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could have been attributed to pre-exiting or underlying medical conditions. It is also 
possible that false negative results might occasionally occur for another reason. Because 
all test results were not evaluated in concert with a clinical diagnosis and history due to 
unavailability of clinical diagnosis and history. Lastly, we did not use another 
confirmatory test in this study. DBS samples giving discrepant treponemal test results (17 
false negatives) need to be further tested by another confirmatory method using either the 
FTA-ABS or PCR analysis. 
5.3 Recommendations 
Based on our findings, the study clearly showed DBS underestimated positive 
results mainly at low OD level, which could be due to the low blood volume in the spot. 
In particular, research should focus on further optimization of the assay using different 
cut-off values for the validation of the positivity and negativity in DBS samples because 
the small amount blood in the DBS specimens leads to lower assays titer.  
The TREP - SPOT
TM
 DBS EIA may be suitable for the detection of antibodies T. 
pallidum and warrant further evaluation using a larger sample size in the study. A higher 
sample size gives more accurate results. Sample size is important primarily because of its 
effect on statistical power.  Statistical power is the probability that a statistical test will 
indicate a significant difference when there truly is one. Attention to sample size will 
result in a more meaningful study, with results more representative of the population, 
which the research is geralizing. A high sample size of the study should be considered 
early in the planning phase of the study. 
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5.4. CONCLUSION 
The use of dried blood spots is often the best sampling option for the detection of 
anti-treponemal antibodies for the diagnosis of syphilis in limited resource settings. The 
study findings indicate that DBS are a feasible alternative to serum/plasma for serological 
confirmation of syphilis. The detection anti-treponemal antibodies compared favorably to 
the results of serum-based assay (TREP-SURE
TM
) EIA, with a specificity of 100% and  
an overall concordance of 91.5%. 
Even though the results from DBS samples showed a lower relative sensitivity 
(83%), dried blood spots are technically easier to obtain and are suitable blood samples 
for primary health care centers. DBS can be collected from a heel, toe, and finger prick or 
prepared from venous blood. The relative ease of sample collection, transport, and 
storage are significant benefits. 
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